Shares of biopharmaceutical company Soleno Therapeutics, Inc. (SLNO) were in the spotlight on Monday after the company ...

INDICATION VYKAT XR is indicated for the treatment of hyperphagia in adults and pediatric patients 4 years of age and older with Prader-Willi syndrome (PWS). Contraindications Use of VYKAT XR is ...

Soleno Therapeutics stock has surged over 1,500% ... ACADIA Pharmaceuticals Inc. (ACAD) has a Phase 3 study of its candidate ACP-101, an intranasal formulation of carbetocin, a long-acting ...

Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) traded down 6.7% during mid-day trading on Tuesday ...

In this article, we are going to take a look at where Soleno Therapeutics Inc. (NASDAQ:SLNO) stands against other firms that end Friday strong. Wall Street’s main indices finished the trading ...

Soleno Therapeutics, Inc. has a 12 month low of $36.61 and a 12 month high of $60.92. The company has a market cap of $2.30 billion, a P/E ratio of -15.09 and a beta of -1.70.

In this article, we are going to take a look at where Soleno Therapeutics Inc. (NASDAQ:SLNO) stands against other stocks that jumped, defying market uncertainties on Thursday. The stock market ...

In this article, we are going to take a look at where Soleno Therapeutics Inc. (NASDAQ:SLNO) stands against other stocks that outperformed broader market last week. Wall Street’s main indices ...